PhD
Research Assistant Professor, Hematology
UNC-Chapel Hill
Molecular Therapeutics
Area of Interest
My research group studies the molecular and cellular mechanisms that contribute to adverse cardiovascular events in cancer patients receiving chemotherapy and targeted therapies.
Cancer therapy associated thrombosis and cancer therapy associated cardiac toxicity represent significant sources of morbidity in this patient population. Using clinical epidemiological approaches, my group seeks to identify novel associations with emerging cancer therapies and adverse cardiovascular complications. These novel associations are used to inform highly translational preclinical studies that seek mechanistic insights into the underlying pathogenesis.
Using preclinical disease models, we seek to identify novel approaches to prevent cancer therapy associated pathologies with a view to improving the quality of life for patients with cancer.
Awards and Honors
- Eberhard F Mammen Award, Seminars in Thrombosis and Hemostasis, 2024
- Kenneth M Brinkhous Prize, American Heart Association, 2024
- Travel Award, International Society of Thrombosis and Haemostasis, 2023
- Abstract Achievement Award, American Society of Hematology, 2022
- Junior Faculty Development Award, UNC Chapel Hill, 2022
- Prof Heimburger Award, CSL Behring, 2021
- Editors Award, Journal of Thrombosis and Haemostasis, 2021
- Fellowship, Sigma Xi Scientific Research Honors Society, 2018
- Young Investigator Travel Award, American Heart Association, 2018
- Drs Man and Kang Wong Memorial Prize, King’s College London, 2014
